I'm sure many on here keep an eye on the M & A activity. The link below is a great too which has a database at the bottom detailing deals that have been made. The summary tab also allow you to view deals by size and also deal premium.
Since Biogen took over Reata in July there have been two large value deals- Bristols acquisition of Mirati Therapeutics for $4.8b on 08/10 and earlier this week Roche acquired Televant for $7.1b.
https://www.biopharmadive.com/news/biotech-pharma-deals-merger-acquisitions-tracker/604262/
Share Price, page-7511
-
- There are more pages in this discussion • 4,165 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$13.92 |
Change
0.130(0.94%) |
Mkt cap ! $1.779B | |||
| Open | High | Low | Value | Volume |
| $13.66 | $14.03 | $13.46 | $11.10M | 803.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 1608 | $13.91 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $13.99 | 250 | 1 |
View Market Depth
| Last trade - 16.10pm 05/09/2024 (20 minute delay) ? |
| NEU (ASX) Chart |